Highbridge Capital Management’s CERo Therapeutics CERO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-546	Closed	-$11M	–	551
2022 Q3	$11M	Buy	546 +31	+6%	+$627K	0.16%	178
2022 Q2	$10.3M	Sell	515 -2	-0.4%	-$40.1K	0.24%	146
2022 Q1	$10.3M	Sell	517 -2	-0.4%	-$40K	0.24%	121
2021 Q4	$10.3M	Buy	+519	New	+$10.3M	0.22%	151